News

Dr. Christoph Borchers and Dr. Rene Zahedi will be serving as Guest Editors of a Special Issue on "New Insights on Mass Spectometry Applied to Bioscience” in the International Journal of Molecular Sciences. For more information on how to submit a manuscript visit: https://www.mdpi.com/journal/ijms/special_issues/MS_Bioscience

 

 

Join us at the "37th International Symposium on Microscale Separation and Bioanalysis" where Dr. Christoph Borchers will be presenting a Keynote Lecture!

https://msb-conferences.org/sessions-keynotes/ 

 

 

We're excited to announce that the Canada Foundation for Innovation grant is providing $3.1 million of a $9.1-million equipment upgrade for The Metabolomics Innovation Centre (TMIC) with a newly formed Canadian Analytics Network for Outcome Prediction In Exposures (CANOPIE)—a collaborative project between the U of A, McGill University and the University of Calgary.

Read more at https://www.ualberta.ca/folio/2021/03/equipment-upgrades-will-boost-innovative-metabolomics-research-linking-environmental-exposures-with-health-outcomes.html"

 

 

 

Our special issue on Structural Proteomics in the Journal of Proteomics is now on-line!  

Edited by Paulo C Carvalho, Fabio Gozzo, Tatiana Brasil, Christoph Borchers 

https://www.sciencedirect.com/journal/journal-of-proteomics/special-issu... 

 

L’entreprise MRM Proteomics se prépare à analyser, dès qu’elle obtiendra les approbations, une quarantaine d’échantillons sanguins par jour provenant de personnes atteintes de la COVID-19. Son but : trouver des biomarqueurs dans la concentration de protéines et de métabolites dans le sang pour mettre au point un test en mesure de prédire les séquelles de la maladie que le patient risque d’éprouver après son hospitalisation. « Si vous le savez, vous pouvez réaliser un suivi plus serré », explique Christoph Borchers, professeur à l’Université McGill et chef de la direction scientifique de MRM Proteomics.
La Presse
https://www.lapresse.ca/affaires/portfolio/2020-10-21/sciences-de-la-vie/production-biopharmaceutique-les-maillons-forts-de-la-chaine-quebecoise.php

 

 

 

 

 

May 2020

Our PhD student Vincent Lacasse was awarded the FRSQ scholarship for project entitled: " Développement d’un essais en spectrométrie de masse ciblée pour les proteins des points de contrôles immunitaires"

 

November 2019

Megagrant project from Center for Computational and Data-Intensive Science and Engineering have received funding from Russian Ministry of Science and High Education: Dr. Christoph Hermann Borchers and his new laboratory project “Next-Generation Proteomics to Improve Personalized Medicine and Health Care”. (Laboratory for Mass-spectroscopy), (duration 2 years, 33 mln RUB/yr).

 

August 2019

The UVic group has contributed 954 of the over 2350 targeted human and mouse MRM-based assays to the Assay Portal of the National Cancer Institute (https://proteomics.cancer.gov/news_and_announcements/more-validated-targ...)

 

April 2019

Doctoral candidate Georgia Mitsa of Dr. Christoph Borchers’ proteomics lab received two awards from McGill University:
• the Dr. Gerald B. Price Memorial Travel Award from the Department of Experimental Medicine; and the
• Grad Excellence Award in Experimental Medicine.  

 

 

September 2018
We welcome two new colleagues, Vanessa Gaspar working on an FRQS-funded project and Evgeniy Petrotchenko who is an expert in Structural Proteomics.

 

June 2018
We are proud to be part of the Montreal Cancer Consortium (MCC) that has been recently funded by the Terry Fox Foundation and other co-funders. “Working together, the MCC researchers will also aim to better understand how various aspects of the immune system relate to acute leukemia and why therapy works for some patients but not others. They hope to identify new biomarkers and novel targets that will respond to immunotherapy treatments.” See press release (www.tfri.ca/en/NewsEvents/news/news-releases-detail/2018/06/28/the-terry...)

 

 

 

Back to top